Browsing by Author "Szczech, Lynda A."
Now showing items 1-4 of 4
-
A secondary analysis of the choir trial shows that comorbid conditions differentially affect outcomes during anemia treatment
Szczech, Lynda A.; Barnhart, Huiman X.; Sapp, Shelly; Felker, G. Michael; Hernandez, Adrian; Reddan, Donal; Califf, Robert M.; Inrig, Jula K.; Patel, Uptal D.; Singh, Ajay K. (Elsevier BV, 2010-02-01)The CHOIR trial in anemic patients with chronic kidney disease compared epoetin-alfa treatment with low (11.3 g/l) and high (13.5 g/l) hemoglobin targets on the composite end point of death, hospitalization for heart ... -
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes
Inrig, Jula K.; Patel, Uptal D.; Toto, Robert D.; Reddan, Donal N.; Himmelfarb, Jonathan; Lindsay, Robert M.; Stivelman, John; Winchester, James F.; Szczech, Lynda A. (Elsevier BV, 2009-11-01)Pulse pressure is a well established marker of vascular stiffness and is associated with increased mortality in hemodialysis patients. Here we sought to determine if a decrease in pulse pressure during hemodialysis was ... -
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the choir (correction of hemoglobin and outcomes in renal insufficiency) trial
Inrig, Jula K.; Barnhart, Huiman X.; Reddan, Donal; Patel, Uptal D.; Sapp, Shelly; Califf, Robert M.; Singh, Ajay K.; Szczech, Lynda A. (Elsevier BV, 2012-09-01) -
Secondary analysis of the choir trial epoetin-α dose and achieved hemoglobin outcomes
Szczech, Lynda A.; Barnhart, Huiman X.; Inrig, Jula K.; Reddan, Donal N.; Sapp, Shelly; Califf, Robert M.; Patel, Uptal D.; Singh, Ajay K. (Elsevier BV, 2008-09-01)Trials of anemia correction in chronic kidney disease have found either no benefit or detrimental outcomes of higher targets. We did a secondary analysis of patients with chronic kidney disease enrolled in the Correction ...